Canopy sticks to profit vow despite revenue miss By Reuters

<iframe src=”//rcm-na.amazon-adsystem.com/e/cm?o=1&p=22&l=ur1&category=homegarden&banner=02NMTC702K4D0VHE1SR2&f=ifr&linkID=17e0b4ac3a719000706e772761d8ae0e&t=forexz-20&tracking_id=forexz-20″ width=”250″ height=”250″ scrolling=”no” border=”0″ marginwidth=”0″ style=”border:none;” frameborder=”0″></iframe>

© Reuters. FILE PHOTO: A sign featuring Canopy Growth Corporation’s logo is pictured at their facility in Smiths Falls, Ontario, Canada, January 4, 2018. REUTERS/Chris Wattie/File Photo

By Arunima Kumar and Shariq Khan

(Reuters) -Canopy Growth Corp’s chief executive reassured investors that the world’s most valuable pot producer is on track to be profitable within a year, shrugging off a slightly weaker-than-expected fourth-quarter performance.

The company – which sells a range of products from dried flowers to gummies, to chocolates and drinks mixed with weed – posted a near 38% surge in revenue to C$148.4 million in the quarter but missed estimates of C$151.8 million, according to Refinitiv IBES.

The company’s revenue growth was subdued by a fresh round of COVID-19 related lockdowns in Canada and Germany, Canopy’s CEO David Klein told Reuters in an interview.

While the company is “a little concerned” that the lockdowns, especially in Canada, might also hold back growth in the current quarter, Klein said the company was still on track to be profitable by the end of its current fiscal year.

“The way it looks, there will be sequential improvement (in adjusted EBITDA) throughout the year,” Klein said.

A host of cost-cutting through last year helped Canopy narrow its quarterly adjusted loss before interest, taxes, depreciation, and amortization to C$94 million from C$102 million.

“You have a company that is building on revenue growth success … and a lot of their strategic initiatives are paying off when it comes to the brands they have in their portfolio,” Global X analyst Andrew Little said.

Global X, which owns about 600,000 Canopy Growth (NASDAQ:) shares, runs a cannabis focused ETF.

Klien said the focus was now firmly on the U.S. market, where expectations were rising for federal marijuana reform.

“We’re very happy with our portfolio in Canada and with the ability of that portfolio to travel to the U.S. … wouldn’t see us doing much more in the way of M&A in Canada”, Klein said on a post-earnings call.

($1 = 1.2044 Canadian dollars)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


− 4 = 1